News-Medical.netInduced Pluripotent Stem Cells (iPSCs) and Cell ReprogrammingNews-Medical.netStem cells represent a valuable asset as observed in previous sections. Even though these stem cells exist in embryonic and adult tissues, harvesting copious p… Continue reading
FOX43.com |
FDA cracks down on stem cell clinics
FOX43.com Dr. Elliot B. Lander, co-founder of the California Stem Cell Treatment Center, said it was “voluntarily participating” in “studies for late-stage, no-options cancer patients” that had been approved by institutional review boards. The boards are … |
San Francisco Chronicle |
Gilead to Fly High with Kite Pharma Acquisition for $11.9B
Yahoo Finance We note that Kite is a pioneer in cell therapy having developed engineered cell therapies that express either a chimeric antigen receptor (CAR) or an engineered T cell receptor (TCR), depending on the type of cancer. The most advanced therapy candidate … ‘Game-changer’ cancer treatment is focus of Gilead’s $12 billion cell therapy dealSan Francisco Chronicle Gilead to Become Cell Therapy Leader Once $11.9B Acquisition of Kite Pharma ClosesLymphoma News Today Gilead’s $11.9 billion purchase of a groundbreaking cancer therapy could drag it into a new debate on pricesWashington Post Fairfield Daily Republic –San Francisco Business Times –Drug Discovery & Development –Zacks Investment Research all 63 news articles » |
89.3 KPCC |
FDA cracks down on stem-cell clinics selling unapproved treatments …
89.3 KPCC Adult stem cells can be extracted from human fat. Patrick T. Fallon/The Washington Post/Getty Images. 169120 full. Share. Share via Email email; Share on … FDA Cracking Down On Unapproved Stem Cell TreatmentsThe Onion (satire) FDA announces action against two stem cell clinics: Is that a ‘crackdown’?HealthNewsReview.org FDA Stem Cell Clinics Crackdown: Agency Targets Unproven TreatmentNewsmax Pain News Network –FDA.gov all 28 news articles » |
|
Gene Therapy for the Eyes: Ophthalmology Times
MedPage Today One expert explores how to manage suprachorodial hemorrhage effectively using a minimally invasive surgical technique. According to Paul Sieving, director of the National Eye Institute, “There is a compelling need to explore gene therapy in the eye.”. |